Composition:
- A fixed-dose combination of Rosuvastatin and Micronised Fenofibrate
- Each film-coated tablet contains:
- Rosuvastatin 10 mg
- Fenofibrate (micronised) 160 mg
Azuvas 10 F: Effect on lipid parameters
Parameters |
Rosuvastatin 10 mg |
Fenofibrate 160 mg |
Azuvas 10 F |
LDL |
- 52% |
- 19.1% |
Additive |
TG |
- 37% |
- 28.1% |
Additive |
HDL |
+ 14% |
+ 11% |
Additive |
Fenofibrate – Non- Lipid Actions
- Reductioninserumuricacidlevels
- Loweringofserumfibrinogenlevels
- Fenofibrateimprovesinsulinsensitivity
Azuvas 10 F : Indications
- Combined/mixed hyperlipidemia
- Diabetic Dyslipidemia
- Patients with CAD not able to achieve goals of therapy with statin monotherapy
Azuvas 10 F : Dosage
- The recommended dosage is one tablet, once daily either morning or evening
- should be given with meals, thereby optimizing the bioavailability of Fenofibrate